ReportWire

Tag: patents

  • New USPTO Director Signals Major Change Afoot for Patents

    [ad_1]

    The right to own what you invent is enshrined in the U.S. Constitution. One question among many for the U.S. patent system right now is how — and how quickly — that right evolves in the age of AI.

    When the U.S. Patent Office opened in 1790, applicants had to submit physical models of their inventions. Today, a majority of utility patents filed in the United States involve software.

    Yet, for more than a decade now, ambiguity over which kinds of software-related inventions are patentable has disproportionately affected the startups and inventors that depend on patents for leverage.

    The data is clear: Startups with more patents consistently raise more funding. Not because the patents themselves are inherently valuable, but because they signal to investors that a company has something new worth defending. 

    For innovators relying on software and especially AI, that signal has been inconsistent.

    John Squires Rebrands the USPTO

    In late September, John Squires was sworn in as the new USPTO Director — and immediately made clear he intends to change that.

    In his first official remarks, Squires made the unusual choice of describing the USPTO as a “patent factory.” He then took action. As his first official act, he signed two patents — one for distributed-ledger technologies, another for medical diagnostics.

    “These have been areas of great, but in my view unproductive, debate — too often dismissed as ‘mere business methods’ or ‘ineligible diagnostic practices,’” he declared, adding: “The U.S. Patent Office is open for business, especially for the technologies of tomorrow.”

    Days later, Director Squires authored a rehearing decision in Ex parte Desjardins, reversing a Patent Trial and Appeal Board panel that had rejected a machine-learning patent. The reversal included the following broad policy statement:

    “Categorically excluding AI innovations from patent protection in the United States jeopardizes America’s leadership in this critical emerging technology.”

    Together, these early and unconventional moves show a USPTO eager to partner with innovators rather than deny them.

    For software and AI innovators hoping to use patents to raise investment for their companies, this is encouraging news. Veteran software-patent attorney Robert Plotkin called the Desjardins ruling “a very bold, clear statement by the new USPTO Director that he intends to change, perhaps even end, the era of routinely rejecting AI and software patents.”

    Advice for Software and AI Innovators

    As the founder of BlueShiftIP, Plotkin specializes in helping growing technology companies patent their software inventions. He urged innovators to treat the Desjardins ruling as a call to action, offering the following advice in a webinar he held shortly after the news was made public.

    Re-evaluate shelved inventions.

    Machine-learning models, data-processing systems, and algorithmic improvements that deliver measurable technical benefits—think faster training, lower storage use, higher accuracy—may now stand a better chance of allowance at the USPTO.

    “If there are innovations you assumed weren’t going to be patentable… it’s time to revisit those assumptions because the door is starting to reopen at the Patent Office,” he said.

    File while the window is open.

    It’s unclear how long this window is going to last, Plotkin pointed out. Innovators should consider using Track One or other expedited examination options to reach examiners while the current guidance is favorable. (These days, it’s possible to get a utility patent issued in less than a year by paying extra.)

    A Shifting Landscape Inside the USPTO

    The shift in how AI inventions are treated at the USPTO is one of many changes taking place under the new administration. Most notably, as Acting Director, Coke Morgan Stewart used her authority to reject petitions to contest patents through the inter partes review process in greater numbers than ever before.

    Inside the Office, longtime employees have left; others have been let go. On Reddit, patent examiners are expressing concern about whether they’ll have enough time to evaluate patent applications, with rumored changes to how they receive credit for their work coming soon.

    Sudden shifts in policy create uncertainty, and uncertainty makes it harder for innovators to secure the funding they need. Still, the direction is clear: When it comes to these specific technology areas, the USPTO is tilting toward engagement rather than obstruction.

    For entrepreneurs innovating with AI, this could be the first moment in years when patent protection works as a dependable strategic business tool — a way to attract investment, form partnerships, and compete globally.

    The opinions expressed here by Inc.com columnists are their own, not those of Inc.com.

    [ad_2]

    Madeleine Key

    Source link

  • The AI-Powered Patent Check That Is Reducing Risk for Startups and Their Lawyers

    [ad_1]

    AI is changing patent work in the same way spreadsheets changed accounting. The busy-work shrinks, and expert judgment matters more. That shift is good news for founders, investors, and, most crucially, attorneys who want to deliver earlier, more precise answers about, “Can we ship this without stepping on someone else’s patent?” 

    Why AI patent work matters now 

    In fast cycles, teams commit to features, designs, and markets long before the full extent of legal risk is known. Traditional patent searching is thorough but slow and expensive when used as the first step for every idea. AI, however, flips the order. It makes a quick, inexpensive first pass possible at the start, so attorneys can focus time where it counts. 

    What’s an early FTO check  

    Freedom to operate (FTO) is about risk. “Are there patents out there that our product might infringe?” A pre-FTO or triage pass is a fast screen—minutes, not weeks—that scans the landscape and highlights likely collisions. It’s not a legal opinion. It’s a map that says, “Pay attention here,” so counsel can dive deep efficiently. 

    What’s changed about the patent process 

    Modern AI can read and understand any sort of document fast and reliably, break it into claim-like elements—such as features, methods, and signals—and match those against huge patent corpora to surface the closest neighbors. AI is great at recall and ranking. The lawyer is great at boundaries and remedies—deciding if a claim overlaps, proposing a design-around, or advising to avoid jurisdiction. 

    The attorney angle and advantage 

    AI doesn’t replace legal judgment; it routes work to it sooner. That means attorneys can offer productized, fixed-fee “front-door” services without guessing. Think of it as a standard intake: 

    1. Triage: This is fast and low cost. Run the idea through a pre-FTO screen; get a ranked list of potential conflicts with plain-language notes. 
    2. Counsel review: This can be flat or fixed. An attorney interprets the overlaps, tests claim boundaries, and recommends changes (“Use method B, not A; file here, avoid there”). 
    3. Formal opinion: This is customized. Where warranted, the full FTO or targeted non-infringement analysis in specific jurisdictions. 

    Clients get speed and clarity while attorneys spend time on judgment, not on stitching together PDFs and queries. 

    Ultimately, tools make all the difference. For example, Evalify, a Nobody Studios portfolio company led and co-founded by William Carbone and Nick Sgobba, is one of the next-gen tools making that front door workable. Teams upload a short product brief or even a presentation deck. The system maps it to relevant patents and returns a preliminary FTO score with the closest references and a readable rationale in minutes. Attorneys then take that packet as the starting point for review, strategy, and, when needed, formal opinions. It’s the intake layer, not the last word. 

    Guardrails that make this safe 

    • Privilege and confidentiality: Matter data is isolated, logs are auditable, and default settings avoid cross-matter training, unless a client explicitly opts in. 
    • Explainability: This is every reference link to why it was flagged. No black-box magic is required to justify the next steps. 
    • Right tool, right moment: Pre-FTO is for early decisions. It doesn’t replace patentability searches, litigation strategy, or full clearance opinions. 

    It’s a win-win for the whole startup ecosystem 

    • Founders and product leaders can add deck-to-pre-FTO to their idea checklist before locking the roadmap. This equals cleaner calls, earlier. 
    • Investors can ask portfolio companies for a triage pass at the proposal stage. This reduces avoidable risk and speeds de-risking. 
    • Attorneys and firms can now offer a clear entry product—priced, scoped, and fast. They’ll use AI to widen the top of the funnel and reserve expert time for what they do best. 

    The future of patent work 

    AI won’t practice law, and it definitely won’t replace attorneys. However, it will make the front end of patent risk faster, cheaper, and easier to understand. It will also do this at a more predictable, if not fixed, cost. Firms that produce this intake—and founders who make it a habit—will move faster with fewer surprises. That’s not disruption for disruption’s sake. It’s simply better timing for everyone. 

    The opinions expressed here by Inc.com columnists are their own, not those of Inc.com.

    [ad_2]

    Peter Economy

    Source link

  • Bank of America granted 1,100 AI patents since 2022

    Bank of America granted 1,100 AI patents since 2022

    [ad_1]

    Bank of America has secured nearly 1,100 AI and machine learning patents since 2022 as it continues to invest in innovation.  The bank posted a 94% increase in AI and machine learning patents since 2022, driven by customer demand for innovation and simplifying tasks, according to the bank’s latest patent report, released this month.   “Our […]

    [ad_2]

    Courtney Blackann

    Source link

  • Bank of America patent portfolio includes 1,100 AI patents

    Bank of America patent portfolio includes 1,100 AI patents

    [ad_1]

    Bank of America has secured nearly 1,100 AI and machine learning patents since 2022 as it continues to invest in innovation.  The bank posted a 94% increase in AI and machine learning patents since 2022, driven by customer demand for innovation and simplifying tasks, according to the bank’s latest patent report, released this month.   “Our […]

    [ad_2]

    Courtney Blackann

    Source link

  • Can Cannabis Strains Be Patented?

    Can Cannabis Strains Be Patented?

    [ad_1]

    Emily Mullins

    Posted by Emily Mullins on 04/02/2024 in Cannabis Laws

    Can Cannabis Strains Be Patented?Can Cannabis Strains Be Patented?

    Cannabis “strains” are distinct genetic varieties of the cannabis sativa plant that are bred for certain desirable characteristics such as aroma, terpene profile, potency, or flavor. Although it seems strange to patent a breathing, developing live organism, plants have been granted patents in the United States since the 1930s, with the very first plant patent being issued to Henry Bosenberg for a special breed of rose in 1931.

    For breeders and cultivators, patenting a cannabis strain can provide advantages by granting exclusive rights to unique genetic compositions and desirable traits inherent in a particular plant. With patent protection, a breeder can benefit from compensation for their investment of time, resources, and expertise into developing novel cannabis varieties with enhanced properties. 

    How are Strains Created?

    Cannabis breeders combine traditional horticultural techniques with modern scientific knowledge of genetics.

    Typically, a breeder will select parent plants, a male and a female plant, that exhibit desired traits, such as high potency, unique flavors, or specific medicinal properties. Then, these ideal parent plants are cross-pollinated to create diverse offspring with traits combined from both parents in a process called selective breeding. Pollen is extracted from a male plant and then gently deposited onto the flowers of the female plant, and seeds develop within six weeks.

    Through successive generations of careful selection, breeders isolate and stabilize desired traits while eliminating undesirable ones over time. Ultimately, the aim is to develop plants that offer consumers unique, appealing characteristics. 

    Patenting Plants

    A plant patent is an intellectual property right granted to protect an inventor’s discovery or cultivation of a new variety of plants. The Plant Patent Act states that:

    “Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state, may obtain a patent therefor…”

    Plants discovered in nature cannot be patented, because they occur spontaneously through biological processes and were not invented. Someone is said to have “invented” a plant and is eligible for a plant patent if the person created a novel and unique variety of a plant that they are able to reproduce asexually, such as by grafting.

    Additionally, the plant eligible for a plant patent must have been altered by the inventor to the extent that the resulting organism is considered non-naturally occurring. Obtaining a plant patent ultimately ensures that an inventor, who invested labor and skill into producing a novel plant product, has protection from other growers cloning the plant or selling the plant and any of its parts.

    Plants can also be designated as intellectual property with a utility patent, which provides more comprehensive protection. A plant patent is limited to protecting a single plant and its direct descendants, so the patent does not cover plants grown from the seeds of the patented mother plant, just clones of the mother plant and its parts.

    On the other hand, a utility patent gives its owner the right to prevent any person in the US from making, using, selling, or importing the plant itself as well as its clones, tissues, or even individual cells, regardless of whether the plant is sexually or asexually produced. In order to obtain this type of patent, the cannabis plant must not be naturally occurring, and it must demonstrate usefulness and novelty, and its innovation must be non-obvious. 

    Patenting a Cannabis Strain

    Although it is federally illegal in the United States to possess, distribute, or cultivate cannabis plants (that do not meet the standards for classification as “hemp”), the US still grants patent protection for illegal substances just as they do for legal inventions. As long as an inventor can prove that their cannabis plant is novel, distinct, and non-natural, the plant is eligible for a US patent, and as of 2021, 12 patents for cannabis plant varieties have been issued.

    Thus, under plant patents and utility patents, you can patent strains of cannabis. To apply for a patent, the inventor must prove that they discovered or created a strain that is not naturally occurring and is different from other existing plants by at least one distinguishing characteristic which is not caused by growing conditions (like fertilizers, etc.). Furthermore, the inventor must prove that the invention was not obvious to somebody with ordinary skills. These patents last around 20 years. 

    A patent application for either a plant or utility patent to protect your cannabis strain must contain information such as:

    • What plants/breeds were crossed,
    • Description of plant phenotype, botanical features, and properties that distinguish the plant from other known plants,
    • If the plant was propagated asexually, technical details about the manner and placement of propagation,
    • Pictures of the plant, 
    • A certificate of analysis (depending on the state) or some other scientific description of how reported cannabinoid levels were ascertained. 

    The Future of Cannabis Patents

    While intellectual property rights offer incentives for innovation and investment in the development of novel cannabis plants, these legal protections also raise concerns about accessibility to medicinal cannabis and potential monopolization by corporate entities.

    With substantial financial resources, extensive legal teams, and established market networks, large corporations possess a distinct advantage in navigating the complexities of the patenting process. Patents cost money, and small-scale growers can be effectively out-competed by enterprises in possession of more resources to conduct massive breeding operations and ultimately claim more numerous and more optimized strains for themselves.

    Large corporations can leverage their resources to invest in sophisticated cultivation facilities to conduct extensive research and accelerate the creation of unique strains with desirable traits. Moreover, wealthier companies have greater access to distribution channels, which enables them to scale up production and reach a wider consumer base, thus profiting more from their creations than small-scale growers.

    Despite the risk of monopolization in the industry, patenting cannabis plants is a relatively new phenomenon, and we are living through a future that holds promise for exciting discoveries, unforeseen opportunities, and novel experiences of the effects offered by the cannabis plant.

    [ad_2]

    Source link

  • 1 in 5 TD patents are AI-related | Bank Automation News

    1 in 5 TD patents are AI-related | Bank Automation News

    [ad_1]

    To provide personalized customer experiences, TD Bank is developing AI technology, which has resulted in more patents for the company.   “TD has filed more than 450 patent applications in relation to AI [since 2020],” Senior Vice President and Chief Architect Licenia Rojas said on May 15 during TD Tech and Innovation Day. TD has […]

    [ad_2]

    Vaidik Trivedi

    Source link

  • illumiPure, Inc. Secures Multiple Patents for World’s Safest LED Lighting Technology

    illumiPure, Inc. Secures Multiple Patents for World’s Safest LED Lighting Technology

    [ad_1]

    illumiPure®, Inc., a leader in innovative LED solutions, is proud to announce two patents for its CleanWhite® 405 nm and 405/470 white light LEDs, the only LED to receive a Risk Grade 0 (EG 0) / Exempt Status rating for safety after IEC 62741 testing. This groundbreaking technology has been patented in the European Union and Japan, adding to the North American patent in 2022. CleanWhite LEDs combine traditional white light illumination, disinfection, circadian rhythm management, and remove the most harmful spectrums of blue light, setting a new standard in health and safety protocols for any indoor environment.

    CleanWhite LEDs are the world’s safest white light LED, being awarded exempt status after IEC 62741, which tests the safety of lighting on skin and eyes. This provides a superior solution to traditional LED lighting. To date, CleanWhite LEDs are the only LEDs to receive Risk-Exempt status after testing.

    CleanWhite LED’s uniqueness is providing a solution that delivers white light illumination, disinfection, and circadian rhythm management, all within a single LED that also removes harmful blue light. The LED uses 405 nm diode in lieu of traditional 450 nm diode to create white light illumination, and in doing so, eliminates the most harmful parts of the blue light spectrum, blue light between 440 and 450 nms.

    In addition, 405 nm light, spiked in the CleanWhite LED, is a powerful disinfectant, making the CleanWhite LED the first and only single LED chip that provides white light illumination and disinfection in a single diode. Unlike conventional disinfection LEDs that require switching modes to activate disinfection, illumiPure’s patented CleanWhite 405 LED fixtures deliver continuous disinfection on surfaces and in the air while emitting pleasant, normal white light.   

    The CleanWhite 405/470 LED also enhances the 470 nm wavelength of light, providing additional circadian rhythm management. The disruption of circadian rhythm, which can be caused by harmful blue light wavelengths, is now being linked to a host of maladies and adverse conditions, including everything from cognitive decline, fatigue, headaches, and trouble learning to increased risk of diabetes, weight gain, and even some cancers.

    “Our innovative LED technology is a game changer for any indoor space,” said illumiPure’s CEO John C. Higgins, “Growing evidence shows the detrimental effects that hazardous blue light has on all of us. CleanWhite LED chips and fixtures not only increase users’ health by removing a host of infectious pathogens but also can help reduce adverse effects to the circadian rhythm of shift workers.” 

    “With patents now secured in multiple European Union countries and Japan, we are poised to deliver this unique solution globally, ensuring environments are not only well-lit but also continuously disinfected, all without compromising human safety or comfort,” added Chris Vennard, the company’s Chief Compliance Officer.

    For more information about illumiPure, Inc. and its technologies, including the new CleanWhite LEDs, please visit www.illumipure.com. 

    Source: illumiPure, Inc.

    [ad_2]

    Source link

  • Feds make a pharma patent grab

    Feds make a pharma patent grab

    [ad_1]

    The Biden administration may take redistribution to new extremes if a policy revision floated in December comes to fruition. The White House wants to give federal agencies the right to seize some pharmaceutical patents when they deem drug prices too high.

    President Joe Biden claims authority to act under the Bayh-Dole Act of 1980, which lets nonprofits and small businesses retain ownership of inventions made possible by federal contracts, grants, or cooperative agreements—so long as they patent and license these inventions. Its impetus was all the innovation languishing under government ownership.

    “In 1980, the federal government had approximately 30,000 patents, of which only 5% led to new or improved products,” according to the Syracuse University Office of Technology Transfer. The government simply didn’t “have the resources to develop and market the inventions.”

    Under the Bayh-Dole system, it’s easier for inventions (including pharmaceuticals) to get from the research stage to the market stage. Since the point of the law is to let the public benefit from innovation, it contains a stipulation saying the government can take ownership of an invention if an institution doesn’t commercialize it.

    This stipulation, known as “march-in rights,” was designed as a safeguard against the system being abused by companies who might purchase licenses solely to keep competitors from using new technology. The government has never actually exercised march-in rights before. But they can apply if a patent holder doesn’t commercialize an invention in a timely manner or tries to license it on unreasonable terms, among a few other reasons. Notably, these reasons do not include “the White House thinks it’s priced too high.”

    “The purpose of our act was to spur the interaction between public and private research so that patients would receive the benefits of innovative science sooner,” wrote former Sens. Birch Bayh (D–Ind.) and Bob Dole (R–Kan.), in a 2002 Washington Post op-ed. They noted that even when early-stage research was government-funded, the financial and temporal input required from private industry was still substantial. “Bayh-Dole did not intend that government set prices on resulting products” or be able to revoke a license “contingent on the pricing of a resulting product.”

    Now the Biden administration wants to allow use of the law in a way its creators explicitly stated it was not intended to be used. “When drug companies won’t sell taxpayer-funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House economic adviser Lael Brainard told reporters in December.

    To this effect, the Department of Health and Human Services and the Department of Commerce have proposed a new framework that allows price to be a factor in determining whether to exercise march-in rights. If enacted, it would effectively give the government control over the price of drugs.

    [ad_2]

    Elizabeth Nolan Brown

    Source link

  • This Tiny Website Is Google’s First Line of Defense in the Patent Wars

    This Tiny Website Is Google’s First Line of Defense in the Patent Wars

    [ad_1]

    A trio of Google engineers recently came up with a futuristic way to help anyone who stumbles through presentations on video calls. They propose that when algorithms detect a speaker’s pulse racing or “umms” lengthening, a generative AI bot that mimics their voice could simply take over.

    That cutting-edge idea wasn’t revealed at a big company event or in an academic journal. Instead, it appeared in a 1,500-word post on a little-known, free website called TDCommons.org that Google has quietly owned and funded for nine years. Until WIRED received a link to an idea on TDCommons last year and got curious, Google had never spoken with the media about its website.

    Scrolling through TDCommons, you can read Google’s latest ideas for coordinating smart home gadgets for better sleep, preserving privacy in mobile search results, and using AI to summarize a person’s activities from their photo archives. And the submissions aren’t exclusive to Google; about 150 organizations, including HP, Cisco, and Visa, also have posted inventions to the website.

    The website is a home for ideas that seem potentially valuable but not worth spending tens of thousands of dollars seeking a patent for. By publishing the technical details and establishing “prior art,” Google and other companies can head off future disputes by blocking others from filing patents for similar concepts. Google gives employees a $1,000 bonus for each invention they post to TDCommons—a tenth of what it awards its patent seekers—but they also get an immediately shareable link to gloat about otherwise secretive work.

    TDCommons adds to Google’s long-standing, and far more vocal, efforts to carve out greater space for freewheeling innovation in an industry where patents can be used to hobble or extract cash from competitors. The site may be dowdy and obscure, but it does the trick. “The beauty of defensive publications is that this website can be pretty simple,” says Laura Sheridan, Google’s head of patent policy. “It needs to establish a date. And it needs to have documents be accessible. There’s not much more we need to do.”

    In reality, the experiment has struggled to cut through government bureaucracy and overcome competition from more robust archives. Sheridan acknowledges it’s a work in progress. TDCommons needs a bigger flow of uploads to become less peculiar and more vital. It offers a unique hope of expanding public access to the technical creativity happening inside corporate walls—and shifting more resources toward that work.

    Playing Defense

    The strategy underpinning TDCommons dates back decades to the 1950s, when invention powerhouses IBM and later Xerox began publishing journals filled with what they called technical disclosures. They’d then ship the journals to patent offices, in part to serve as prior art, staking a claim on the ideas contained within. About 84 percent of patent applications denied by the US Patent and Trademark Office in the 12 months ending September 2023 were scuppered at least in part by prior art, according to the agency.

    During the early-2000s internet boom, entrepreneurs saw an opportunity to bring these defensive publications, or dpubs, to databases online. IP.com is widely considered the leader, with 215,000 inventions uploaded so far and searchable access to millions of additional documents from outlets including open-access research library arXiv.org. Unlike TDCommons, posting to or accessing IP.com isn’t free. Uploading a dpub costs $395 for up to 25 pages, while viewers pay $40 for individual downloads or $49 monthly for unlimited access. The USPTO is one of IP.com’s largest customers, according to the company, with subscriptions for most of the agency’s 9,200 examiners and supervisors.

    [ad_2]

    Paresh Dave

    Source link

  • Apple can sell its latest smartwatches again after court pauses FTC import ban

    Apple can sell its latest smartwatches again after court pauses FTC import ban

    [ad_1]

    The latest Apple Watches are available again after the company scored a legal victory Wednesday.

    “We are thrilled to return the full Apple Watch lineup to customers in time for the new year,” Apple
    AAPL,
    +0.05%

    said in a statement to MarketWatch. “Apple Watch Series 9 and Apple Watch Ultra 2, including the blood-oxygen feature, will become available for purchase again in the United States at Apple Stores starting today and from apple.com tomorrow by 3 p.m. ET.”

    A U.S. appeals court earlier Wednesday temporarily blocked a government commission’s import ban on popular Apple Watch models following a patent dispute with medical-technology firm Masimo Corp.
    MASI,
    -4.57%
    .

    The court’s order allows Apple to temporarily resume selling the Apple Watch Series 9 and Apple Watch Ultra 2. Both watches were pulled from Apple’s website last week and off store shelves this week when the ban went into effect. The appeals court is weighing a longer halt on the import and sales ban.

    Masimo declined to comment.

    On Tuesday, the tech giant filed an emergency request for the U.S. Court of Appeals for the Federal Circuit to halt the ban at least until U.S. Customs and Border Protection decides whether redesigned versions of its watches infringe Masimo’s patents.

    The appeals court’s decision will allow the U.S. Customs department to consider Apple’s redesign of the offending Apple Watch models. A fix is expected by Jan. 12. Apple said in the motion Tuesday it could “suffer irreparable harm” if the ban is kept in place while the appeal is ongoing.

    Shares of Apple were flat in trading Wednesday.

    [ad_2]

    Source link

  • 5 Things to Look for When Hiring a Patent Portfolio Manager | Entrepreneur

    5 Things to Look for When Hiring a Patent Portfolio Manager | Entrepreneur

    [ad_1]

    Opinions expressed by Entrepreneur contributors are their own.

    Hiring a patent portfolio manager is a milestone that will enhance your enterprise’s patent program. Managing the patent process efficiently becomes more difficult at scale without dedicated staffing. Without proper planning, your inventors’ hard-won innovations risk being under-protected by your enterprise.

    Hiring an incompetent patent portfolio manager may result in valuable ideas remaining unpatented, a decrease in innovator engagement, unjustified patent prosecution costs and an inadequate return on your IP investments.

    Unearthing patents from your innovators requires a patent portfolio manager with technical expertise, standout interpersonal skills and undeterred persistence. Simultaneously, strengthening your patent portfolio against competitors demands significant patent-related experience. And generating maximum returns on IP investments demands sound business acumen.

    An adept patent portfolio manager should possess a diverse skill set aligned with your enterprise’s objectives. Evaluating candidates on these five key competencies can help you select the right one:

    • Technical expertise

    • Legal experience

    • Eye for detail

    • Interpersonal skills

    • Business acumen

    Read on as we delve deeper into these core attributes.

    Related: An Entrepreneur’s Guide to Inventing

    1. Technical expertise

    Inventors typically have a lot on their plate. Their primary focus is on innovation and product development with little time for the administrative tasks needed to keep the patent program running. Amid their busy schedules, they might overlook reporting their innovations for patenting.

    Sometimes, they might even dismiss an invention as too obvious, deciding not to report it at all. Consequently, you may miss out on potentially patentable ideas.

    A portfolio manager who is familiar with your enterprise’s technology can have conversations with the inventors, guiding them on which ideas should be protected. Ideally, a seasoned employee or someone acquainted with your enterprise’s technological focus would be suitable. They need not understand all the innovation, but they should have enough background knowledge to identify and capture the best ideas.

    2. Legal experience

    Addressing complex queries about the likelihood of getting a patent, complete life-cycle cost estimates and strategic filing decisions across multiple jurisdictions can be challenging without legal experience.

    Moreover, interacting with outside patent counsel in the absence of knowledge of patent terminology can lead to ineffective communication. Ineffective communication between a patent portfolio manager and outside counsel can lead to misunderstandings about strategic patent goals, potential delays in the patent prosecution process, increased costs and unsuccessful patent filings. These complications can, in turn, jeopardize the enterprise’s intellectual property strategy to protect its market.

    A patent portfolio manager with legal experience, potentially from a law firm or corporate role, can effectively communicate with counsel, answer intricate questions and guide the implementation of cost-effective patent filing strategies across multiple jurisdictions.

    3. Eye for detail

    Managing large patent portfolios with hundreds of matters across different countries can be overwhelming due to extensive tracking, communication and administrative work.

    Moreover, patent rights for an invention are given country by country. It’s perplexing to efficiently navigate the complexities of obtaining patent rights across different countries. Coordinating with legal counsel in each jurisdiction, managing numerous email correspondences, answering specific questions, reaching out to the right individuals and getting signatures demands an eye for detail.

    A detail-oriented patent portfolio manager can handle large patent portfolios effectively. With a strong understanding of your enterprise processes and excellent organizational skills, they ensure timely responses. They also excel at obtaining necessary approvals and signatures while maintaining a well-organized administration.

    Related: The Basics of Protecting Your Intellectual Property, Explained

    4. Interpersonal skills

    Inventors must intensely focus on their product innovation with little time to engage in extensive paperwork. Distractions and delays in submitting invention disclosures can starve your patent pipeline. This results in a rushed patenting process, seeking patent protection just before product launch.

    Besides, it’s not unusual for enterprise members, legal counsel or foreign associates to be awaiting answers or information. The intensity of delivering a product leaves little time to focus on the big picture.

    Given the multitude of outstanding queries and patent-related tasks in an enterprise, this role requires strong interpersonal skills and diligence. Mining patents requires constant sleuthing to find what the inventors are doing. The patent manager must build solid relationships with inventors and establish clear communication channels for efficient reporting of potential inventions, ensuring all stakeholders receive timely information.

    5. Business acumen

    Enterprises often face challenges in aligning their patent strategies with wider business goals.

    It’s daunting to gauge the commercial potential of patents, navigate patent licensing negotiations and make strategic litigation decisions, all while ensuring cost-effectiveness. Alignment of the patent program with strategic goals requires focus and an even keel.

    Thus, unlocking the true market potential of your patent portfolio demands that the patent portfolio manager possesses strong business acumen.

    Related: Create the Strongest Patent Possible With These 5 Tips

    A capable patent portfolio manager can prove to be more cost-effective and yield better results in comparison to being dependent on an organic process internally or even on outside legal counsel for various tasks like mining patents, strengthening patent portfolios and generating higher returns on IP investments.

    The perfect candidate for the patent portfolio manager position should demonstrate a combination of technical proficiency, legal background, attention to detail, strong interpersonal skills and business acumen.

    Recruiting one can be a challenging task, but often the best candidates are right under your nose. They might be among the external counsel you already work with, exhibiting proficiency in tasks you need to get done at competitive costs. It could even be found within the enterprise with a prolific inventor having an interest in a bigger role in the legal department. These professionals could transition into a full-time role within your enterprise.

    Drawing from over 25 years of experience in patent prosecution, I can vouch that hiring a competent patent portfolio manager, as outlined in this post, can contribute positively to your enterprise’s success in conquering your patent landscape. You can further empower your patent portfolio manager by adopting the right patent management software.

    [ad_2]

    Thomas Franklin

    Source link

  • Ocado to Receive GBP200 Mln in Settlement from AutoStore

    Ocado to Receive GBP200 Mln in Settlement from AutoStore

    [ad_1]

    By Christian Moess Laursen

    Ocado Group said Monday that it has reached an agreement to settle all litigation with Norwegian peer AutoStore over e-commerce patent claims.

    The online grocer and retail-technology specialist said AutoStore will pay Ocado 200 million pounds ($257.1 million) in 24 monthly installments starting this month.

    The settlement includes a cross-licence of certain patents between the two companies, whereby they both have freedom to access and use technology covered by each other’s pre-2020 patents.

    The agreement gives access to part of each company’s patent portfolio for both of them to use or develop their own products, Ocado said.

    The settlement ends a three-year row that started in 2020, when AutoStore filed a claim for patent infringement against Ocado regarding e-commerce tech.

    Write to Christian Moess Laursen at christian.moess@wsj.com

    [ad_2]

    Source link

  • How to Showcase the Value of Your Patents | Entrepreneur

    How to Showcase the Value of Your Patents | Entrepreneur

    [ad_1]

    Opinions expressed by Entrepreneur contributors are their own.

    Determining the market potential of patents can be a complex task for entrepreneurs. The value of a patent doesn’t necessarily equal the investment, and it may indeed be significantly higher or lower.

    The worth of a patent, or a collection of patents, depends on numerous factors. The operational context of the patent in question largely influences its potential value.

    A patent’s value can vary greatly, particularly when considering its role. It may serve as a tool to attract investment or act as a strategic asset during a lawsuit.

    Understanding your patent’s potential is a crucial endeavor. It forms a cornerstone of your business’s growth strategy and protective measures.

    Related: Top 5 Intellectual-Property Challenges Businesses Face

    The value of a patent in a business transaction

    It’s easier to realize value from a patent when it’s part of the sale of a thriving business. In this case, it’s actively generating income and acts as a hedge against competition. An investor will see it as protection for their investment.

    Also, when a business is marketed with a patent or patent portfolio, it serves as persuasive evidence to the buyer that the patent office has acknowledged its uniqueness. This is why patents or patent portfolios constitute a significant aspect of negotiations when companies are sold, merged or divested. Issued patents are a seal of approval that the business has technology that is differentiated.

    In fact, given two companies with similar characteristics, VCs and investors will prefer to purchase a company with a patent portfolio protecting their products or unique production processes. Additionally, a recent study in the Journal of Business and Venturing shows that companies with a patent portfolio get a larger valuation than those without during VC funding rounds.

    Why?

    A company without a patent is vulnerable to licensing demand or even lawsuits.

    Admittedly, the company may have never been sued before the acquisition because they’re too small to pay substantial settlements. However, they become an attractive target for patent infringement lawsuits once they’re purchased by a larger corporation with deep pockets or otherwise well-funded. Going public can also attract unwanted patent assertions or threats.

    So, a patent that’s part of a successful business and a hedge against competition is easier to value. Protection of the business and the attraction of investment proves its value.

    Related: Significance of Patents For Various Ventures

    When the patent stands alone

    Consider a scenario where you have a patent that is not linked with any business, possibly because you’re in the initial stages of your entrepreneurial journey or the industry pivoted.

    Proving the value of a patent that hasn’t been utilized or generated any industry attention can be challenging. In such situations, the patent often appears as a distressed asset, making its value speculative.

    In such situations, you’re required to employ creative strategies to demonstrate the patent’s value through unconventional methods. They include:

    Demonstrate infringement:

    It attracts interest if you demonstrate the widespread use of your patents in the industry. Significant potential damages could be at stake. Non-practicing entities who enforce patents for business may consider acquisition under these circumstances. Check out the top 10 patent acquirers paying big in 2023.

    The first step is to conduct research to find others doing similar things. Then create claim charts and other supporting research to demonstrate patent infringement within the industry.

    Initiate your research by leveraging the capabilities of user-friendly, AI-powered patent search tools. Should you spot potential, it could be beneficial to engage a research firm for the identification of possible patent infringers who can map the patent claims to particular products.

    Identify court cases involving the patent:

    There may be instances where someone tried to challenge your patent in court, but it was confirmed to be valid. Maybe the court further ruled that they infringed on the patent. Or there may be a settlement or licensing by others. This proves that your patent is indeed valuable.

    You can then evaluate the market and look at other people who have filed patents, successfully licensed patents or are successfully selling products in that area. It becomes easier to calculate potential damages and for people to understand the risks they might face where there is third-party affirmation.

    However, it’s quite rare to use this method to prove the value of your patent. Furthermore, winning the first litigation doesn’t assure subsequent ones could be lost.

    Turn distress into an opportunity:

    Another approach is to identify competitors facing off against each other in the marketplace or the courtroom. For insights into potential lawsuits, consider following blog posts from reputable IP research firms. Alternatively, establish a Google alert to stay updated on patent infringement news.

    If one of those competitors happens to be infringing upon the patents you are selling, you have the opportunity to strategically approach the other competitor and offer them an additional powerful weapon to strengthen their battle arsenal.

    Related: What Good Is a Patent if You Can’t Enforce It?

    Uncovering the market potential of your patent portfolio, whether linked with a successful business or standalone, requires careful strategy. The goal is to effectively demonstrate the worth of your patent rights, either by emphasizing its protective power for a business, proving its value through legal victories or identifying infringers.

    Although determining your patent’s potential value is complex, it’s worthwhile. Your patent is more than a paper tiger — it can be a strategic asset driving business success or providing a solid return on innovation investments.

    Feel free to get in touch with further queries on this topic. Until then, best of luck in your patent valuation journey!

    [ad_2]

    Thomas Franklin

    Source link

  • Super crops are coming: Is Europe ready for a new generation of gene-edited plants?

    Super crops are coming: Is Europe ready for a new generation of gene-edited plants?

    [ad_1]

    Brussels is finalizing a law to legalize new gene-editing technologies for crops across the European Union.

    The EU’s ultra-restrictive GMO regulation, which predates newer technologies, sets extremely high hurdles for growing genetically engineered crops and allows EU countries to ban them even after they have been proven to be safe.

    The new law aims to cut red tape and allow easier market access for plants grown with “new genomic techniques” (NGTs), such as CRISPR-Cas9, which target specific genes without necessarily introducing genetic material from outside the breeders’ gene pool.

    The rules are being pushed by multinationals such as Bayer, Syngenta and Corteva, which together control the lion’s share of the plant breeding sector, as well as a host of smaller companies, scientists and farmers’ groups such as Copa-Cogeca.

    They argue that the EU risks falling behind the rest of the world in using new crops with special traits that can make them more nutritious, efficient and better adapted to a changing climate.

    Pitted against them are green lawmakers, environmental advocacy groups, organic and small farmers, and more than 400,000 EU citizens who have signed a petition against deregulating what they call “new GMOs.”

    These groups say the rules will further tighten the grip of the handful of multinationals, allowing them to claim patents on crops that could have been obtained through conventional breeding methods, while threatening non-GM and organic production. They also argue that because NGTs have only been around for just over a decade, questions remain about their safety.

    According to a leaked draft, EU countries will no longer be able to ban the cultivation of NGT crops.

    The law simplifies rules even more for a sub-group of NGT crops that are deemed equivalent to crops obtained by traditional breeding techniques. The obligation to label foods as “GMO” will no longer apply to these “conventional-like” plants, and they won’t be subject to risk assessment by food safety regulators.

    An earlier draft of the law had a carve-out for crops engineered to tolerate herbicides — which would still have been subject to the stricter GMO rules. However, a newer draft no longer makes such a distinction.

    The European Commission is due to unveil the proposed law on gene-edited crops on Wednesday, as part of the latest package of measures under its Green Deal environment and sustainability agenda. This will include a new law on soil health, revisions of the food waste and textiles aspects in the EU Waste Framework Directive, and legislation on seeds and other plant and forest reproductive material.

    [ad_2]

    Bartosz Brzezinski and Jakob Hanke Vela

    Source link

  • Silence speaks volumes as Switzerland still reels from bank meltdown

    Silence speaks volumes as Switzerland still reels from bank meltdown

    [ad_1]

    Press play to listen to this article

    Voiced by artificial intelligence.

    ZURICH — In one of Europe’s wealthiest squares, overlooked by the looming headquarters of a huge international bank that disintegrated just weeks ago, the impeccably dressed men and women who shuffle in and out of gleaming offices are in the grip of a Mafia-like omertà.

    “You won’t get anything from anyone,” one of them says with a firmness that’s meant to draw a line under any conversation before it’s even begun. The informal code of silence dominates. His friend drags him away, through the doors of a second global bank — the one that rescued the first for 3 billion Swiss francs.

    This is Paradeplatz in Zurich, Switzerland’s biggest city. Home to Credit Suisse, whose collapse in March after 167 years could have triggered a full-on global crisis had UBS not been forced to step in and take it over. The recriminations started almost immediately. Now, amid its rattling trams and luxury chocolate shops, this 17th-century square could rival the Vatican for the way the fog of secrecy has descended.

    Stay there long enough and an occasional whisper about the demise of the once-great bank might be overheard. Speculation, nothing more. Gossip about political repercussions or what could happen to bonuses — exchanged over strong coffee and furtive early-morning glances at the Financial Times or Neue Züricher Zeitung. But not with outsiders of course, and certainly not with those who approach with journalist notebook in hand.

    It’s easy to spot the bankers in the Swiss financial capital: a perfectly tailored blue suit, single-breasted trench coat, hand-held briefcase (leather, preferably). And what about the demise of Credit Suisse, then? “We can’t talk about it,” says one of them over an espresso with a colleague.

    Turn the corner, to where a younger man is smoking, behind the dead bank’s HQ that still stands at Paradeplatz’s northern end. He dismisses all questions too: “For that, we have corporate comms.”

    Nobody’s responsible

    There’s a reason for all this silence. The Alpine nation, known for its utmost discretion in its role as banker to the world’s rich, is still trying to process exactly what went wrong — and what to do about the people who took Credit Suisse to the brink.

    The public is “very angry,” according to Tobias Straumann, professor of modern and economic history at the University of Zurich, especially as it’s been just 15 years since UBS’ own public bailout.

    “The taxpayer has to save a bank, where people earned a lot of money, and nobody’s responsible now,” he said. “That’s the feeling.”

    With national elections coming up in October, the question turns to who will be on the receiving end of that feeling. Just the bankers themselves? The regulators who watched it go up in flames? The politicians who set the rules in the first place? All of the above?

    The Swiss parliament has started exerting its authority — rejecting the government’s request to approve an emergency credit line underpinning the takeover. But that was largely symbolic. It will decide in June whether to launch a parliamentary commission — which would then be able to summon those involved for questioning.

    The Swiss parliament has started exerting its authority — rejecting the government’s request to approve an emergency credit line underpinning the takeover | Fabrice Coffrini/AFP via Getty Images

    “My prediction would be that in the short run, not much is going to happen,” Straumann said. “But probably after the elections, then you’re going to see a bigger coalition that really does something,”

    Pig market

    It won’t help the public mood that some Credit Suisse bankers plan to sue over lost bonuses. A few hundred years ago Paradeplatz was known as Säumärt — pig market, and now accusations of snouts in troughs have become ever more common in public discourse.

    Céline Widmer, a Swiss Social Democrat lawmaker, has called for a ban on bankers’ bonuses, as well as for higher capital requirements for lenders to make them safer. In her view, Switzerland’s financial watchdog should also get stronger sanctioning powers.

    “It was the behavior of the banks, which [demonstrated] they are not accountable,” she said of what went wrong at Credit Suisse.

    The Swiss authorities find themselves under intense scrutiny. Although they stopped the bank’s collapse from triggering broader financial contagion, the government and regulators face questions over why they didn’t step in earlier.

    As it was, Credit Suisse had problems for years, but over a few days in March, it rapidly lost the trust of financial markets amid broader panic over bank failures in the U.S.

    According to Finance Minister Karin Keller-Sutter, the bank would have run out of money without the hasty takeover by UBS, as clients pulled their deposits and its shares and bond prices tanked.

    The government promised to swallow up to 9 billion francs of losses if needed and the Swiss central bank offered 100 billion francs of liquidity.

    Legal cases are underway contesting the decisions taken over that pivotal weekend of the merger — including the Swiss financial watchdog’s wipeout of 16 billion francs of Credit Suisse bonds, reversing the usual hierarchy of losses in a collapse.

    Those investors, whose bonds are now worth nothing, have won an early victory by forcing the release of a contested emergency decree.

    A banking monster

    And life might get harder for the other bank with its headquarters in Paradeplatz now that it’s gobbled up its rival.

    “We created a monster with UBS,” said Thomas Borer, a former Swiss ambassador to Germany, who is involved in representing the interests of Credit Suisse bondholders wiped out in the takeover.

    “[It’s now] one of the biggest banks in the world when it comes to wealth management. We are not one of the biggest countries in the world. How should we regulate that? That’s now where the debate is focusing on.”

    According to Finance Minister Karin Keller-Sutter, the bank would have run out of money without the hasty takeover by UBS | François Walschaerts/AFP via Getty Images

    The parliamentary investigation could lead that debate — and even Switzerland’s tight-lipped bankers are keen.

    “We are supporting that there be an independent and complete and open-minded review of these events,” said August Benz, deputy chief executive of the Swiss Bankers Association.

    Credit Suisse’s failure had triggered “certain emotions,” Benz said, but hoped an inquiry would help Switzerland pick “the right measures” in response to the bank’s failure. He pushed back against the idea that a global bank like UBS could be too big for the country.

    “Germany has one [globally systemic bank], Italy has one, Spain has one, [the Netherlands has one] and Switzerland looks like it’ll have one,” he said.

    Stable no more

    Back on the streets of Zurich, Credit Suisse’s HQ is a visible reminder of the uncertainty brought about by its failure, peering over at UBS across Paradeplatz.

    “It’s a huge institution that suddenly disappears,” says Reinhard Berger, a 36-year-old chemist, waiting for the tram.

    A few blocks away, Eliane Christen, a patent engineer, 35, is wistful. The failure makes her “unsure about the stability we always say Switzerland has,” she says. The stability seemed to vanish in one weekend.

    [ad_2]

    Hannah Brenton

    Source link

  • 5 Benefits Patent Management Software Must Deliver | Entrepreneur

    5 Benefits Patent Management Software Must Deliver | Entrepreneur

    [ad_1]

    Opinions expressed by Entrepreneur contributors are their own.

    A properly managed patent portfolio can be an organization’s most valuable asset.

    A robust patent portfolio can protect investments by safeguarding product lines and defending against competitor litigation and infringement. A strong patent portfolio can also deliver the value necessary to raise investment funds, collaborate with partners and strengthen a company’s position in mergers, acquisitions and other transactions.

    Recent data technology advancements, such as machine learning and artificial intelligence, have eliminated many manual processes and have made patent data increasingly accessible to small and large businesses.

    Patent management software uses patent data analytics to help businesses prepare and organize patent applications, manage patent portfolios and make data-based strategic decisions. Without a patent management tool, it’s difficult and expensive to gain the value that a patent portfolio provides.

    If you’re considering starting or building a patent portfolio and want to maintain it efficiently, you’ll need a patent management tool that’s versatile and comprehensive.

    Here are five benefits an optimized patent management software solution delivers:

    Related: The Basics of Protecting Your Intellectual Property, Explained

    1. Reduced legal fees

    A patent management tool synched with the U.S. Patent and Trademark Office (USPTO) can provide automatic status updates that outside counsel would otherwise bill you for. When powerful data science provides the information to track your case, you can make intelligent decisions based on the same knowledge that was once only available to your law firm.

    Save time and money with real-time status that eliminates the need to call your attorney, wait for updates and pay for information.

    A patent management software solution that delivers easy-to-understand patent portfolio status reports enables you and your staff make timely and informed decisions.

    2. Greater patent prosecution efficiency

    Patent prosecution — the process by which you obtain a patent — entails drafting, filing and negotiating issuance with the patent office. The likelihood of successfully prosecuting a case often depends on the allowance rate of the examiner assigned to the case.

    The more you know about the examiner’s allowance history, the better you can negotiate and make informed decisions about how to pursue the case. A patent management tool that lets you know how the examiner handling your case tends to respond puts you in the driver’s seat when choosing the right course of action.

    3. Patent vetting

    Any process by which you’re vetting and selecting ideas to draft and file requires input and collaboration from stakeholders familiar with the technical benefits, budget considerations and strategic vision.

    A patent management tool that facilitates interaction between these players is critical to discovering and moving forward with the most promising ideas without lengthy meetings. Actionable intelligence like cost and allowance predictions allow for finding the most promising ideas for protection.

    Features like simultaneous editing, the ability to comment on ideas and documented changes assist in capturing the best thinking within an enterprise. Tools like these, which allow for online and real-time collaboration, can ensure a patent portfolio that aligns with a company’s strategic vision and budget.

    Related: Want to Patent an Idea? Consider These 3 Tips

    4. Assistance in effective IP budget execution

    Efficient budget spend is crucial for getting the most value from your patent portfolio.

    The key to effective IP budget spending often begins with aligning your strategy with your portfolio and ensuring that patents are compatible with those goals.

    Are you building a defensive patent portfolio or one for acquisition? Is the goal to assert your patents or license them? Do you have aspirations to get into new markets? Being clear on your strategy will help you determine which patents to pursue or prune to best allocate budget dollars.

    Patent management software that allows you to categorize, summarize and rank cases using objective measures provides the first steps toward getting a clear picture of your portfolio and how it can achieve your strategy.

    This type of analysis helps you determine which cases no longer have value so you can cut them, license or auction them off to free up your budget for better opportunities.

    5. Multiple innovation dashboards

    Zeroing in on the precise data you need helps you stay on top of your patent pipeline as well as make timely and informed decisions.

    Role-specific dashboards for inventors, managers, patent practitioners and admin provide relevant perspectives for particular different stakeholders. Everyone involved in the patent program gets their bespoke view with appropriate rights for their involvement.

    Dashboards that list ideas submitted and filed by their team allow managers to track inventors and the stages they’re working on or stuck at. They can also help identify prolific innovators who have submitted the most ideas or filed the most patents. Filters allow you to focus the interface further for a given query.

    Multiple dashboards can help you gain visibility into every corner of your innovation pipeline to stay aligned with company strategies and KPIs.

    Related: 4 Ways to Significantly Reduce the Cost of Obtaining New Patents and Managing IP

    Patent management software is essential for organizing and managing your patent portfolio. With it, you can easily track the progress of your patents and get timely answers to all your questions.

    How many patents have been issued? What is the status of various filings? How many patents are there on a particular product line? A hard-working patent management tool provides the answers you need to stay on top of your innovation pipeline for the entire lifecycle of your patents. It saves you time and money, and it helps you meet your company’s strategic goals.

    A well-curated patent portfolio can give you the competitive advantage you need to protect your patent assets and take new products to market. The right patent management software facilitates thoughtful management of every stage of that process.

    [ad_2]

    Thomas Franklin

    Source link

  • Bank of America lands record number of tech patents | Bank Automation News

    Bank of America lands record number of tech patents | Bank Automation News

    [ad_1]

    Bank of America was granted a record 608 patents last year by the U.S. Patent and Trademark Office, a 19% rise year over year. Key automation technologies such as AI and machine learning (ML) applications were at the fore, alongside information security and payment end uses, emanating from a diverse global workforce. The bank rose […]

    [ad_2]

    Neil Ainger

    Source link

  • Vaya Space Awarded Multiple Patents for Vortex-Hybrid Engine Technology

    Vaya Space Awarded Multiple Patents for Vortex-Hybrid Engine Technology

    [ad_1]

    Press Release


    Aug 9, 2022

    Vaya Space, the vortex-hybrid engine rocket company and emerging leader in sustainable space access, announced today that the United States Patent and Trademark Office (USPTO) has awarded two patents to the Company on its breakthrough vortex-hybrid propulsion technology. 

    Privately held Vaya Space, with operations in both the U.S. and Brazil, has recently emerged as one of the leaders in the space industry and small satellite launch sector. The Company took a technology-first and different approach than many of its well-funded competitors, and as such has recently gained credibility from numerous industry leaders through recent agreements with NASA and major satellite customers that have selected Vaya Space as their launch provider for their constellations.   

    The Company’s first patent was awarded for its unique production process of its 3D-printed fuel grain that enables higher performance through uniform burn throughout the entirety of the engine. The second patent protects Vaya’s vortex flow field injection system design. The vortex flow of liquid oxygen through the 3D lathe printed rocket engine combines with Vaya’s other technologies to deliver more than 110 kN of thrust per engine, up to 350 seconds of ISP, and eliminates the instability and other issues that have plagued hybrid engines of the past decades.  

    Rob Fabian, Chief Operating Officer of Vaya Space, commented, “These two patent awards are a testament to the world-class engineering team at Vaya, and we are just getting started. Breakthrough doesn’t begin to define what we have recently accomplished. We see no barrier to transforming this and adjacent industries, and expect to make a difference for the environment in the process.”   

    Vaya’s rocket engines are produced using more than 20 metric tons of recycled thermoplastics and deliver industry-leading payload performance at a substantially lower cost than competitors. Vaya’s engines have zero TNT explosive equivalency and utilize materials that are non-toxic, non-hazardous, and require no special handling, storage or transportation. Vaya’s rocket engines use substantially fewer components resulting in improved reliability, are far less costly to produce, and operate with substantially lower emissions.  

    The awarding of Vaya’s two patents, multiple additional intellectual property in its pipeline, and the recent contracts and agreements with satellite customers and NASA have positioned Vaya as not just the greenest rocket company in the industry, but also the emerging leader and low-cost provider in the sector. 

    About Vaya Space, Inc.

    Vaya Space is a privately owned, vortex-hybrid rocket company based on the Space Coast of Florida with subsidiary operations in Brazil. Vaya Space has developed breakthrough and patented technologies that transform access to space. Vaya was created in 2017 by Sid Gutierrez, former Space Shuttle Commander and NASA’s first U.S.-born Hispanic astronaut. Launch Command’s final words to Sid at liftoff were “Vaya con Dios” vs. its traditional “Godspeed,” and shortly after this inspiration, Vaya was born.

    Vaya is a purpose-driven, sustainability focused, and environmentally conscious enterprise dedicated to making a difference for humankind. Vaya Space competes within the small satellite launch sector of the space industry, a market estimated to grow to $1 trillion over the next decade. Vaya’s unique vortex-hybrid rocket utilizes the equivalent of two million recycled plastic bottles per launch and overcomes the costs and other issues associated with traditional liquid or solid rockets to transform the safety, affordability, and sustainability of the industry.

    Additional information found at vayaspace.com.

    For inquiries, please contact:

    Vaya Space Investor Relations
    Kevin Lowdermilk
    +1 703 346-6826
    Kevin.Lowdermilk@VayaSpace.com   

    Vaya Space Media Relations 
    Mary Baldino
    +1 321 270-1478
    Mary.Baldino@VayaSpace.com

    Source: Vaya Space

    [ad_2]

    Source link

  • Chicago Comb Company Receives 2 Design Patents for Metal Combs

    Chicago Comb Company Receives 2 Design Patents for Metal Combs

    [ad_1]

    The award-winning Chicago Comb Company has been granted one of the most distinguished awards for their products. They have been issued two design patents for their unique combs by the United States Patent Office.

    Press Release



    updated: May 9, 2017

    The award-winning Chicago Comb Company has been granted one of the most distinguished awards for their products. They have been issued two design patents for their unique combs by the United States Patent Office — one for each of their two flagship products, the design of their Number 1 and Number 2 combs.

    “We couldn’t be happier,” says co-founder John Litwinski. “We’ve spent many hours in crafting not only our unique designs, but we put a lot of attention on creating a high-quality product. We live in a time when it is very easy to copy products. Now that we have these patents, the worry of competitors copying us with inferior products has been taken out of the equation.”

    “We’ve spent many hours in crafting not only our unique designs, but we put a lot of attention on creating a high-quality product. We live in a time when it is very easy to copy products. Now that we have these patents, the worry of competitors copying us with inferior products has been taken out of the equation.”

    John Litwinski, co-founder

    The Chicago Comb Company was founded by two childhood friends, John and Tedd, in 2010. Since starting their business, they have seen a steady growth in sales year after year, and the combs are now featured in retailers in 23 countries across the world. Their passion for quality and their keen sense of detail has brought to life a unique everyday item that will stand the test of time.

    The patented No. 1 and No. 2 combs were the first combs ever to be laser cut out of steel in the US. The combs are then hand finished in their workshop in Chicago. All the steel that makes up the combs is sourced in the US as well as their packaging. 

    “One of our core values is local production. From the laser cutting of the combs to the machine and hand finishing, all are done right here in Chicago. Not a lot of companies can say that — it’s something we are very proud of,” says co-founder Tedd Strom.

    The Chicago Comb Company has expanded over the years, and now offers five different design models of combs, each with a matte, mirror or black finish. In addition, they offer their patented designs in pure American Titanium – the only comb in the world to do so.  Each of their designs is accompanied by a leather sheath using top-quality leather from Chicago’s world-famous Horween tannery.

    They offer custom engraving on their website (www.chicagocomb.com), perfect for any special occasion or event, as well as limited supply of combs featuring the designs of acclaimed artists engraved on the combs.

    Source: Chicago Comb Company

    [ad_2]

    Source link